A General Review of the Effects of Angiotensin-Peptides and 8-Substituted Analogs of Angiotensin II

  • R. Kazim Türker
Part of the NATO ASI Series book series (NSSA, volume 105)


In this short review special attention has been focused on some pharmacological effects of angiotensin peptides which may contribute to its direct physiological function in water and sodium intake.


Tyrosine Hydroxylase Sodium Intake Aortic Strip Dimethyl Glycine Zona Glomerulosa Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    A.P. Smlyo and A.V. Somlyo, Vascular smooth muscle II. Pharmacology of normal and hypertensive vessels, Pharmacolo, Rev., 22:249 (1970).Google Scholar
  2. 2.
    W.B. Campbell, S.N. Brooks and W.A. Pettinger, Angiotensin II and angiotensin Ill-induced aldosterone release in vivo in the rat, Science, 184:994 (1974).PubMedCrossRefGoogle Scholar
  3. 3.
    M.J. Peach, C.A. Sarsted and E.D. Vaughan, Changes in cardiovascular and adrenocortical responses to angiotensin III induced by sodium deprivation in rat, Cir. Res. (Suppl. 2) 38:117 (1976).CrossRefGoogle Scholar
  4. 4.
    R.F. Bing and D. Schulster, Steroidogenesis in isolated rat adrenal glomerulosa cells: response to physiological concentrations of angiotensin II and effects of potassium, serotonin and (Sar1—Ala8)-angiotensin II, J. Endocrinol., 74:261 (1977).PubMedCrossRefGoogle Scholar
  5. 5.
    J. Douglas, G. Aguilera, T. Kondo and K. Catt, Angiotensin II receptors and aldosterone production in rat adrenal glomerulosa cells, Endocrinol., 102:685 (1978).CrossRefGoogle Scholar
  6. 6.
    F.A.O. Mendelsohn and C.D. Kachel, Action of angiotensins I, II and III on aldosterone production by isolated rat adrenal zona glomerulosa cells: Importance of metabolism and conversion pepti-des in vitro, Endocrinol., 106:1760 (1980).CrossRefGoogle Scholar
  7. 7.
    J.T. Fitzsimons and B.J. Simons, The effect on drinking in the rat of intravenous infusion of angiotensin given alone or in combination with other stimuli of thirst, J. Physiol., 203:45 (1969).PubMedGoogle Scholar
  8. 8.
    A.N. Epstein, J.T. Fitzsimons and B.J. Rolls, Drinking induced by injection of angiotensin into the brain of the rat, J. Physiol., 210:457 (1970).PubMedGoogle Scholar
  9. 9.
    J.B. Simpson, A.N. Epstein and J.S. Camardo Jr., The localization of dipsogenic receptors for angiotensin II in the subfornical organ of rat, J. Comp. Physiol, Psychol., 92:581 (1978).PubMedCrossRefGoogle Scholar
  10. 10.
    R.K. Türker, Effect of angiotensin on response to norepinephrine and periarterial stimulation of the isolated perfused cat terminal ileum, Eur. J. Pharmacol., 21:171 (1973).PubMedCrossRefGoogle Scholar
  11. 11.
    R.K. Türker and Z.S. Ercan, Effect of prostaglandin E2 on the pressor response to periarterial stimulation and norepinephrine of the isolated perfused rabbit kidney, Prostaglandins, 9:695 (1975).PubMedGoogle Scholar
  12. 12.
    Z.S. Ercan, Changes induced by angiotensins and prostaglandin E2 on the release of transmitter from isolated perfused rabbit kidney during periarterial stimulation, Ar. int. Physiol. Biochim., 83:799 (1975).CrossRefGoogle Scholar
  13. 13.
    C. Chevillard, N. Duchene and J.M. Alexandre, How angiotensin II increase cardiac dopamine--hydroxylation, J. Pharm. Pharmacol., 27:193 (1975).PubMedCrossRefGoogle Scholar
  14. 14.
    G. Simonnet and M.F. Giorguieff-Chesselet, Stimulating effect of angiotensin II on the spontaneous release of newly synthetized (3H)-dopamine in rat striatal slices, Neuroscience Letters, 15:153 (1979).PubMedCrossRefGoogle Scholar
  15. 15.
    M.C. Boadle-Biber, V.H. III, Morgenroth and R.H. Roth, Activation of tyrosine hydroxylase by angiotensin II and des-(Asp1)-angiotensin II heptapeptide (Abstr.), Pharmacologist, 16:213 (1974).Google Scholar
  16. 16.
    S.M. Friedman and C.L. Friedman, Ionic basis of vascular response to vasoactive substances, Canad. Med. Ass. J., 90:167 (1964).PubMedGoogle Scholar
  17. 17.
    G. Rorive and F. Hagemeijer, Influence de la noradrenaline et de l’angiotensine sur la composition ionique de la fibre musculaire de l’aorte de rat, Ann. Endocr. (Paris), 27:521 (1966).Google Scholar
  18. 18.
    R.K. Türker, I.H. Page and P.A. Khairallah, Angiotensin alteration of sodium fluxes in smooth muscle, Arch. int. Pharmacodyn., 165:394 (1967).PubMedGoogle Scholar
  19. 19.
    R.K. Türker, Effect of angiotensin on the cardiac arrhythmias induced by G-Strophantin, Experientia, 20:707 (1965).CrossRefGoogle Scholar
  20. 20.
    P.A. Khairallah, I.H. Page, F.M. Bumpus and R.K. Türker, Angiotensin tachyphylaxis and its reversal, Circ. Res., 19:247 (1966).PubMedCrossRefGoogle Scholar
  21. 21.
    N.K. Hollenberg, L.R. Barbero and K.P.J. Hinrichs, Angiotensin tachyphylasis and vascular angiotensinase activity, Experientia, 27:1032 (1971).PubMedCrossRefGoogle Scholar
  22. 22.
    R.K. Türker and Z.S. Ercan, Change of activity in rabbit aorta of three analogs of angiotensin substituted in NH2-terminal position, Pharmacology, 13:155 (1975).PubMedCrossRefGoogle Scholar
  23. 23.
    R.W. Schayer, Histamine and circulatory homestasis, Proc. Soc. Exp. Biol Med., 24:1295 (1965).Google Scholar
  24. 24.
    Z.S. Ercan, F.F. Ersoy, T.A. Bökesoy and R.K. Türker, Evidence for the histamine-mediated myotropic effect of angiotensin II in the rabbit aorta, Pharmacology, 18:276 (1979).PubMedCrossRefGoogle Scholar
  25. 25.
    Z.S. Ercan and R.K. Türker, A comparison between prostaglandi releasing effect of angiotensin II and angiotensin III, Agents and Actions, 7:569 (1977).PubMedCrossRefGoogle Scholar
  26. 26.
    A. Blumerg, S. Denny, K. Nishikawa, E. Pure, G. R. Marshall and P. Needleman, Angiotensin Ill-induced prostaglandin(PG)release, Prostaglandins, 11:195 (1976).Google Scholar
  27. 27.
    Z.S. Ercan, F.F. Ersoy and R.K. Türker, The Relaxing effect of angiotensin II and angiotensin III on canin isolated contracted trachéal muscle, J. Pharm. Pharmacol., 30:452 (1978).PubMedCrossRefGoogle Scholar
  28. 28.
    Z.S. Ercan, H. Zengil, F. Akar and R.K. Türker, Possible prosta-cyclin mediated effect of angiotensin II in the isolated perfused rat lung, Pros. Leuk. Med., 12:77 (1983).CrossRefGoogle Scholar
  29. 29.
    R.K. Türker, Evidence for a prostacyclin-mediated chronotropic effect of angiotensin II in the isolated cat right atria, Eur. J. Pharmacol., 83:271 (1982).PubMedCrossRefGoogle Scholar
  30. 30.
    R.K. Türker and Z.S. Ercan, A comparative study with angiotensin II and angiotensin III in the anesthetized cats, Res. Commun. Chem. Pathol. Pharmacol., 21:15 (1978).PubMedGoogle Scholar
  31. 31.
    R. Igic, E.G. Erdös, H.S.Y. Yeh, K. Sorella and T. Nakajima, Angiotensin I converting enzyme of the lung, Cir. Re., 21–22 (Suppl):51 (1972).Google Scholar
  32. 32.
    G. de Caro, M. Massi and L.G. Micossi, Effect of bombesin on drinking induced by angiotensin II, carbachol and water deprivation in the rat, Pharmacol. Res. Commun., 12:657 (1980).PubMedCrossRefGoogle Scholar
  33. 33.
    G. de Caro, M. Mariotti, M. Massi and L.G. Micossi, Dipsogenic effect of angiotensin II, bombesin and tachykinins in the duck, Pharmacol. Biochem. Behav., 13:229 (1980).PubMedCrossRefGoogle Scholar
  34. 34.
    G.R. Marshall, W. Vine and P. Needleman, Specific competitive inhibitor of angiotensin II, Proc. Nat. Acad. Sci. (Wash.), 67:1624 (1970).CrossRefGoogle Scholar
  35. 35.
    R.K. Türker, I.H. Page and F.M. Bumps, Antagonists of angiotensin II, Handbook Exp. Pharmacol., Eds. I.H. Page and F.M. Bumpus, Springer-Verlag, Berlin, New York, V. 37, p. 162 (1974).Google Scholar
  36. 36.
    R.K. Türker and N.O. Gündogan, A comparative study of two structurally related analogs of Asp1-Ile5-angiotensin II, Naunyn—Schmiedeberg’s Arch. Pharmacol., 282:411 (1974).CrossRefGoogle Scholar
  37. 37.
    R.K. Türker, M.M. Hall and F.M. Bumps, Competitive inhbition of Asp1-β-amide-Val5-angiotensin II by Sar1-Ile8-angiotensin II in the cat isolated cardiac muscle and coronary vessels, J. Pharm. Pharmacol., 26:582 (1974).PubMedCrossRefGoogle Scholar
  38. 38.
    D.T. Pals, F.D. Masucci, F. Sipos and G.S. Denning Jr., Specific competitive antagonist of the vascular action of angiotensin II, Cir. Res., 29:664 (1971).CrossRefGoogle Scholar
  39. 39.
    R.K. Türker, M.M. Hall, M. Yamamoto, C.S. Sweet and F.M. Bumpus, A new long-lasting competitive inhibitor of angiotensin, Science, 177:1203 (1972).PubMedCrossRefGoogle Scholar
  40. 40.
    J.R. Blair-West, J.P. Coghan, D.A. Denton, J.W. Funder, B.A. Scoggins and R.D. Wright, Effect of heptapeptide (2–8) and hexapep-tide (3–8) fragments of angiotensin II on aldosterone secretion, J. Clin. Endocrinol. Metab., 32:575 (1971).PubMedCrossRefGoogle Scholar
  41. 41.
    A.L. Blumberg, K. Nishikawa, S.E. Denny, G. R. Marshall and P. Needleman, Angiotensin (AI, AII, AIII) receptor characterization, Cir. Res., 41:154 (1977).CrossRefGoogle Scholar
  42. 42.
    M. Hirata, K. Watanabe, M. Nara, E. Hattori and K. Arakawa, A hexapeptide angiotensin antagonist, des-(Asp1-Arg2)-Ile8-angiotensin II, Endocrinol. Japon., 22:567 (1975).CrossRefGoogle Scholar
  43. 43.
    R.C. Abdulkader, H.B. Silva, M. Marcondes, E.A. Vasconcelos and A.C.M. Paiva, Long-lasting inhibition of angiotensin response in rats by depot administration of octanoyl-Leu8-angiotensin II, J. Pharm. Pharmacol., 31:20 (1979).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1986

Authors and Affiliations

  • R. Kazim Türker
    • 1
  1. 1.Department of Pharmacology Faculty of MedicineUniversity of AnkaraAnkaraTurkey

Personalised recommendations